
CFGI Sentiment Reports · 15 quarters on record since 4 Jan 2023 · updated daily, as of 8 Sep 2026
Bristol Myers Squibb Quarterly Sentiment Reports
Every quarter of Bristol Myers Squibb (BMY) sentiment since 4 Jan 2023, newest first. Each quarter lists its price performance, high, low and average, its sentiment high, low and average, its most volatile day for each, the chart of the whole quarter, the 10 sub-algorithm averages and a short summary. Q3 2026 is the running quarter: an average of 59 (Neutral).
Bristol Myers Squibb sentiment at a glance
- Quarters on record
- 15, since 4 Jan 2023
- Average sentiment, all closed quarters
- 47 of 100 (Neutral)
- Greediest quarter
- Q4 2024, average 58 (Neutral)
- Most fearful quarter
- Q2 2024, average 34 (Fear)
- Best quarter for the BMY price
- Q3 2024, +25.3%
- Worst quarter for the BMY price
- Q2 2025, -22.3%
- Running quarter
- Q3 2026, average 59 (Neutral), BMY price +15.8%
Updated daily; last reading . Every number is computed from CFGI's stored daily readings.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2026 | +13.4%55 | -6.7%44 | +15.8%59 | - |
| 2025 | +7.4%55 | -22.3%41 | -5.1%44 | +13.7%54 |
| 2024 | +2.8%51 | -21.6%34 | +25.3%56 | +6.9%58 |
| 2023 | -4.6%45 | -8.2%42 | -9.9%38 | -11.3%39 |
Bristol Myers Squibb Q3 2026 Sentiment Report
to In progress, updates daily| Performance | +15.8% | 1 Jul 2026 to 8 Sep 2026 |
|---|---|---|
| Price high | $68.09 | 3 Sep 2026 |
| Price low | $56.44 | 1 Jul 2026 |
| Average price | $63.39 | |
| Sentiment high | 77Greed | 28 Jul 2026 |
| Sentiment low | 43Neutral | 6 Jul 2026 |
| Average sentiment | 59Neutral | |
| Most volatile day (price) | -4.0% | 14 Jul 2026 |
| Most volatile day (sentiment) | -27 points (71 to 44) | 5 Aug 2026 |
47 scored trading days of 50. Price is the BMY price; performance is the first to the last scored day.
Q3 2026 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q3 2026, in its own band colour.
- Price61
- Volatility59
- Volume55
- Momentum61
- Technical67
- Social40
- Dominance63
- Trends43
- Whales51
- Orders57
Q3 2026 in brief
Bristol Myers Squibb is averaging 59 of 100 (Neutral) across 47 scored trading days in Q3 2026, opening at 54 on 1 Jul 2026 and reading 43 on 8 Sep 2026. Sentiment ran from 43 (Neutral) on 6 Jul 2026 to 77 (Greed) on 28 Jul 2026. The BMY price moved +15.8% from $56.44 to $65.36, with its biggest single-day move of -4.0% on 14 Jul 2026. The quarter is still open and updates daily.
Bristol Myers Squibb Q2 2026 Sentiment Report
to| Performance | -6.7% | 1 Apr 2026 to 30 Jun 2026 |
|---|---|---|
| Price high | $61.73 | 1 Apr 2026 |
| Price low | $54.00 | 18 Jun 2026 |
| Average price | $57.42 | |
| Sentiment high | 71Greed | 29 Jun 2026 |
| Sentiment low | 24Fear | 7 Apr 2026 |
| Average sentiment | 44Neutral | |
| Most volatile day (price) | +5.2% | 30 Apr 2026 |
| Most volatile day (sentiment) | +27 points (35 to 62) | 30 Apr 2026 |
62 scored trading days of 65. Price is the BMY price; performance is the first to the last scored day.
Q2 2026 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q2 2026, in its own band colour.
- Price47
- Volatility49
- Volume50
- Momentum48
- Technical50
- Socialn/a
- Dominance34
- Trendsn/a
- Whales14
- Orders38
Q2 2026 in brief
Bristol Myers Squibb averaged 44 of 100 (Neutral) across 62 scored trading days in Q2 2026, opening at 69 on 1 Apr 2026 and closing at 68 on 30 Jun 2026. Sentiment ran from 24 (Fear) on 7 Apr 2026 to 71 (Greed) on 29 Jun 2026. The BMY price moved -6.7% from $61.73 to $57.62, with its biggest single-day move of +5.2% on 30 Apr 2026.
Bristol Myers Squibb Q1 2026 Sentiment Report
to| Performance | +13.4% | 2 Jan 2026 to 31 Mar 2026 |
|---|---|---|
| Price high | $62.37 | 27 Feb 2026 |
| Price low | $53.06 | 5 Jan 2026 |
| Average price | $58.30 | |
| Sentiment high | 84Extreme Greed | 6 Feb 2026 |
| Sentiment low | 24Fear | 23 Mar 2026 |
| Average sentiment | 55Neutral | |
| Most volatile day (price) | +4.2% | 7 Jan 2026 |
| Most volatile day (sentiment) | -25 points (76 to 51) | 11 Feb 2026 |
61 scored trading days of 64. Price is the BMY price; performance is the first to the last scored day.
Q1 2026 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q1 2026, in its own band colour.
- Price58
- Volatility53
- Volume53
- Momentum53
- Technical60
- Socialn/a
- Dominance37
- Trendsn/a
- Whales57
- Orders56
Q1 2026 in brief
Bristol Myers Squibb averaged 55 of 100 (Neutral) across 61 scored trading days in Q1 2026, opening at 53 on 2 Jan 2026 and closing at 62 on 31 Mar 2026. Sentiment ran from 24 (Fear) on 23 Mar 2026 to 84 (Extreme Greed) on 6 Feb 2026. The BMY price moved +13.4% from $53.46 to $60.65, with its biggest single-day move of +4.2% on 7 Jan 2026.
Bristol Myers Squibb Q4 2025 Sentiment Report
to| Performance | +13.7% | 1 Oct 2025 to 31 Dec 2025 |
|---|---|---|
| Price high | $54.71 | 24 Dec 2025 |
| Price low | $42.60 | 29 Oct 2025 |
| Average price | $48.11 | |
| Sentiment high | 80Extreme Greed | 5 Dec 2025 |
| Sentiment low | 28Fear | 29 Oct 2025 |
| Average sentiment | 54Neutral | |
| Most volatile day (price) | +7.1% | 30 Oct 2025 |
| Most volatile day (sentiment) | +31 points (28 to 59) | 30 Oct 2025 |
64 scored trading days of 66. Price is the BMY price; performance is the first to the last scored day.
Q4 2025 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q4 2025, in its own band colour.
- Price57
- Volatility53
- Volume54
- Momentum57
- Technical53
- Socialn/a
- Dominance29
- Trendsn/a
- Whales28
- Orders64
Q4 2025 in brief
Bristol Myers Squibb averaged 54 of 100 (Neutral) across 64 scored trading days in Q4 2025, opening at 69 on 1 Oct 2025 and closing at 56 on 31 Dec 2025. Sentiment ran from 28 (Fear) on 29 Oct 2025 to 80 (Extreme Greed) on 5 Dec 2025. The BMY price moved +13.7% from $47.43 to $53.94, with its biggest single-day move of +7.1% on 30 Oct 2025.
Bristol Myers Squibb Q3 2025 Sentiment Report
to| Performance | -5.1% | 1 Jul 2025 to 30 Sep 2025 |
|---|---|---|
| Price high | $48.98 | 23 Jul 2025 |
| Price low | $43.31 | 31 Jul 2025 |
| Average price | $46.70 | |
| Sentiment high | 67Greed | 24 Jul 2025 |
| Sentiment low | 19Extreme Fear | 31 Jul 2025 |
| Average sentiment | 44Neutral | |
| Most volatile day (price) | -5.8% | 31 Jul 2025 |
| Most volatile day (sentiment) | +24 points (29 to 53) | 5 Aug 2025 |
64 scored trading days of 66. Price is the BMY price; performance is the first to the last scored day.
Q3 2025 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q3 2025, in its own band colour.
- Price47
- Volatility48
- Volume48
- Momentum48
- Technical40
- Socialn/a
- Dominance28
- Trendsn/a
- Whales33
- Orders55
Q3 2025 in brief
Bristol Myers Squibb averaged 44 of 100 (Neutral) across 64 scored trading days in Q3 2025, opening at 52 on 1 Jul 2025 and closing at 49 on 30 Sep 2025. Sentiment ran from 19 (Extreme Fear) on 31 Jul 2025 to 67 (Greed) on 24 Jul 2025. The BMY price moved -5.1% from $47.51 to $45.10, with its biggest single-day move of -5.8% on 31 Jul 2025.
Bristol Myers Squibb Q2 2025 Sentiment Report
to| Performance | -22.3% | 1 Apr 2025 to 30 Jun 2025 |
|---|---|---|
| Price high | $59.60 | 2 Apr 2025 |
| Price low | $44.12 | 14 May 2025 |
| Average price | $49.09 | |
| Sentiment high | 70Greed | 12 Jun 2025 |
| Sentiment low | 19Extreme Fear | 10 Apr 2025 |
| Average sentiment | 41Neutral | |
| Most volatile day (price) | -6.1% | 10 Apr 2025 |
| Most volatile day (sentiment) | +24 points (38 to 62) | 19 May 2025 |
62 scored trading days of 65. Price is the BMY price; performance is the first to the last scored day.
Q2 2025 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q2 2025, in its own band colour.
- Price40
- Volatility38
- Volume39
- Momentum40
- Technical39
- Socialn/a
- Dominance32
- Trendsn/a
- Whales92
- Orders45
Q2 2025 in brief
Bristol Myers Squibb averaged 41 of 100 (Neutral) across 62 scored trading days in Q2 2025, opening at 60 on 1 Apr 2025 and closing at 40 on 30 Jun 2025. Sentiment ran from 19 (Extreme Fear) on 10 Apr 2025 to 70 (Greed) on 12 Jun 2025. The BMY price moved -22.3% from $59.55 to $46.29, with its biggest single-day move of -6.1% on 10 Apr 2025.
Bristol Myers Squibb Q1 2025 Sentiment Report
to| Performance | +7.4% | 2 Jan 2025 to 31 Mar 2025 |
|---|---|---|
| Price high | $63.11 | 10 Mar 2025 |
| Price low | $53.90 | 14 Feb 2025 |
| Average price | $58.29 | |
| Sentiment high | 80Extreme Greed | 10 Mar 2025 |
| Sentiment low | 23Fear | 10 Feb 2025 |
| Average sentiment | 55Neutral | |
| Most volatile day (price) | -3.8% | 6 Feb 2025 |
| Most volatile day (sentiment) | -26 points (63 to 37) | 6 Feb 2025 |
60 scored trading days of 64. Price is the BMY price; performance is the first to the last scored day.
Q1 2025 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q1 2025, in its own band colour.
- Price53
- Volatility54
- Volume53
- Momentum53
- Technical59
- Socialn/a
- Dominance37
- Trendsn/a
- Whales85
- Orders74
Q1 2025 in brief
Bristol Myers Squibb averaged 55 of 100 (Neutral) across 60 scored trading days in Q1 2025, opening at 46 on 2 Jan 2025 and closing at 66 on 31 Mar 2025. Sentiment ran from 23 (Fear) on 10 Feb 2025 to 80 (Extreme Greed) on 10 Mar 2025. The BMY price moved +7.4% from $56.79 to $60.99, with its biggest single-day move of -3.8% on 6 Feb 2025.
Bristol Myers Squibb Q4 2024 Sentiment Report
to| Performance | +6.9% | 1 Oct 2024 to 31 Dec 2024 |
|---|---|---|
| Price high | $59.94 | 2 Dec 2024 |
| Price low | $51.92 | 25 Oct 2024 |
| Average price | $55.87 | |
| Sentiment high | 81Extreme Greed | 12 Nov 2024 |
| Sentiment low | 30Fear | 13 Dec 2024 |
| Average sentiment | 58Neutral | |
| Most volatile day (price) | +10.5% | 11 Nov 2024 |
| Most volatile day (sentiment) | +32 points (47 to 79) | 11 Nov 2024 |
64 scored trading days of 66. Price is the BMY price; performance is the first to the last scored day.
Q4 2024 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q4 2024, in its own band colour.
- Price58
- Volatility56
- Volume56
- Momentum55
- Technical65
- Socialn/a
- Dominance34
- Trendsn/a
- Whales80
- Orders79
Q4 2024 in brief
Bristol Myers Squibb averaged 58 of 100 (Neutral) across 64 scored trading days in Q4 2024, opening at 75 on 1 Oct 2024 and closing at 42 on 31 Dec 2024. Sentiment ran from 30 (Fear) on 13 Dec 2024 to 81 (Extreme Greed) on 12 Nov 2024. The BMY price moved +6.9% from $52.90 to $56.56, with its biggest single-day move of +10.5% on 11 Nov 2024.
Bristol Myers Squibb Q3 2024 Sentiment Report
to| Performance | +25.3% | 1 Jul 2024 to 30 Sep 2024 |
|---|---|---|
| Price high | $51.74 | 30 Sep 2024 |
| Price low | $39.66 | 5 Jul 2024 |
| Average price | $46.91 | |
| Sentiment high | 85Extreme Greed | 26 Jul 2024 |
| Sentiment low | 25Fear | 5 Jul 2024 |
| Average sentiment | 56Neutral | |
| Most volatile day (price) | +11.4% | 26 Jul 2024 |
| Most volatile day (sentiment) | -34 points (83 to 49) | 31 Jul 2024 |
64 scored trading days of 66. Price is the BMY price; performance is the first to the last scored day.
Q3 2024 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q3 2024, in its own band colour.
- Price57
- Volatility55
- Volume55
- Momentum56
- Technical56
- Socialn/a
- Dominance28
- Trendsn/a
- Whales70
- Orders68
Q3 2024 in brief
Bristol Myers Squibb averaged 56 of 100 (Neutral) across 64 scored trading days in Q3 2024, opening at 33 on 1 Jul 2024 and closing at 67 on 30 Sep 2024. Sentiment ran from 25 (Fear) on 5 Jul 2024 to 85 (Extreme Greed) on 26 Jul 2024. The BMY price moved +25.3% from $41.30 to $51.74, with its biggest single-day move of +11.4% on 26 Jul 2024.
Bristol Myers Squibb Q2 2024 Sentiment Report
to| Performance | -21.6% | 1 Apr 2024 to 28 Jun 2024 |
|---|---|---|
| Price high | $52.99 | 1 Apr 2024 |
| Price low | $40.25 | 29 May 2024 |
| Average price | $44.75 | |
| Sentiment high | 62Greed | 1 Apr 2024 |
| Sentiment low | 13Extreme Fear | 29 Apr 2024 |
| Average sentiment | 34Fear | |
| Most volatile day (price) | -8.5% | 25 Apr 2024 |
| Most volatile day (sentiment) | -23 points (38 to 15) | 25 Apr 2024 |
63 scored trading days of 65. Price is the BMY price; performance is the first to the last scored day.
Q2 2024 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q2 2024, in its own band colour.
- Price35
- Volatility37
- Volume40
- Momentum40
- Technical39
- Socialn/a
- Dominance22
- Trendsn/a
- Whales41
- Orders27
Q2 2024 in brief
Bristol Myers Squibb averaged 34 of 100 (Fear) across 63 scored trading days in Q2 2024, opening at 62 on 1 Apr 2024 and closing at 38 on 28 Jun 2024. Sentiment ran from 13 (Extreme Fear) on 29 Apr 2024 to 62 (Greed) on 1 Apr 2024. The BMY price moved -21.6% from $52.99 to $41.53, with its biggest single-day move of -8.5% on 25 Apr 2024.
Bristol Myers Squibb Q1 2024 Sentiment Report
to| Performance | +2.8% | 2 Jan 2024 to 28 Mar 2024 |
|---|---|---|
| Price high | $54.40 | 12 Mar 2024 |
| Price low | $47.98 | 5 Feb 2024 |
| Average price | $50.94 | |
| Sentiment high | 75Greed | 7 Mar 2024 |
| Sentiment low | 32Fear | 1 Feb 2024 |
| Average sentiment | 51Neutral | |
| Most volatile day (price) | -3.2% | 13 Mar 2024 |
| Most volatile day (sentiment) | -23 points (72 to 49) | 13 Mar 2024 |
61 scored trading days of 65. Price is the BMY price; performance is the first to the last scored day.
Q1 2024 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q1 2024, in its own band colour.
- Price51
- Volatility50
- Volume48
- Momentum52
- Technical44
- Socialn/a
- Dominance22
- Trendsn/a
- Whales73
- Orders65
Q1 2024 in brief
Bristol Myers Squibb averaged 51 of 100 (Neutral) across 61 scored trading days in Q1 2024, opening at 65 on 2 Jan 2024 and closing at 72 on 28 Mar 2024. Sentiment ran from 32 (Fear) on 1 Feb 2024 to 75 (Greed) on 7 Mar 2024. The BMY price moved +2.8% from $52.76 to $54.23, with its biggest single-day move of -3.2% on 13 Mar 2024.
Bristol Myers Squibb Q4 2023 Sentiment Report
to| Performance | -11.3% | 2 Oct 2023 to 29 Dec 2023 |
|---|---|---|
| Price high | $57.85 | 2 Oct 2023 |
| Price low | $48.48 | 21 Nov 2023 |
| Average price | $52.49 | |
| Sentiment high | 64Greed | 13 Dec 2023 |
| Sentiment low | 12Extreme Fear | 27 Oct 2023 |
| Average sentiment | 39Fear | |
| Most volatile day (price) | -6.4% | 26 Oct 2023 |
| Most volatile day (sentiment) | +25 points (23 to 48) | 3 Nov 2023 |
63 scored trading days of 65. Price is the BMY price; performance is the first to the last scored day.
Q4 2023 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q4 2023, in its own band colour.
- Price37
- Volatility46
- Volume48
- Momentum45
- Technical38
- Socialn/a
- Dominance20
- Trendsn/a
- Whales61
- Orders49
Q4 2023 in brief
Bristol Myers Squibb averaged 39 of 100 (Fear) across 63 scored trading days in Q4 2023, opening at 29 on 2 Oct 2023 and closing at 50 on 29 Dec 2023. Sentiment ran from 12 (Extreme Fear) on 27 Oct 2023 to 64 (Greed) on 13 Dec 2023. The BMY price moved -11.3% from $57.85 to $51.31, with its biggest single-day move of -6.4% on 26 Oct 2023.
Bristol Myers Squibb Q3 2023 Sentiment Report
to| Performance | -9.9% | 3 Jul 2023 to 29 Sep 2023 |
|---|---|---|
| Price high | $64.73 | 5 Jul 2023 |
| Price low | $57.89 | 27 Sep 2023 |
| Average price | $61.27 | |
| Sentiment high | 70Greed | 24 Jul 2023 |
| Sentiment low | 19Extreme Fear | 27 Jul 2023 |
| Average sentiment | 38Fear | |
| Most volatile day (price) | -4.2% | 27 Jul 2023 |
| Most volatile day (sentiment) | +26 points (32 to 58) | 20 Jul 2023 |
63 scored trading days of 65. Price is the BMY price; performance is the first to the last scored day.
Q3 2023 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q3 2023, in its own band colour.
- Price41
- Volatility44
- Volume43
- Momentum44
- Technical39
- Socialn/a
- Dominance20
- Trendsn/a
- Whales26
- Orders42
Q3 2023 in brief
Bristol Myers Squibb averaged 38 of 100 (Fear) across 63 scored trading days in Q3 2023, opening at 37 on 3 Jul 2023 and closing at 30 on 29 Sep 2023. Sentiment ran from 19 (Extreme Fear) on 27 Jul 2023 to 70 (Greed) on 24 Jul 2023. The BMY price moved -9.9% from $64.43 to $58.04, with its biggest single-day move of -4.2% on 27 Jul 2023.
Bristol Myers Squibb Q2 2023 Sentiment Report
to| Performance | -8.2% | 3 Apr 2023 to 30 Jun 2023 |
|---|---|---|
| Price high | $70.74 | 6 Apr 2023 |
| Price low | $63.71 | 30 May 2023 |
| Average price | $67.06 | |
| Sentiment high | 66Greed | 6 Apr 2023 |
| Sentiment low | 17Extreme Fear | 28 Apr 2023 |
| Average sentiment | 42Neutral | |
| Most volatile day (price) | -3.2% | 26 Apr 2023 |
| Most volatile day (sentiment) | -29 points (60 to 31) | 26 Apr 2023 |
62 scored trading days of 65. Price is the BMY price; performance is the first to the last scored day.
Q2 2023 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q2 2023, in its own band colour.
- Price46
- Volatility47
- Volume46
- Momentum46
- Technical43
- Socialn/a
- Dominance20
- Trendsn/a
- Whales22
- Orders56
Q2 2023 in brief
Bristol Myers Squibb averaged 42 of 100 (Neutral) across 62 scored trading days in Q2 2023, opening at 64 on 3 Apr 2023 and closing at 32 on 30 Jun 2023. Sentiment ran from 17 (Extreme Fear) on 28 Apr 2023 to 66 (Greed) on 6 Apr 2023. The BMY price moved -8.2% from $69.69 to $63.95, with its biggest single-day move of -3.2% on 26 Apr 2023.
Bristol Myers Squibb Q1 2023 Sentiment Report
to| Performance | -4.6% | 4 Jan 2023 to 31 Mar 2023 |
|---|---|---|
| Price high | $74.53 | 6 Feb 2023 |
| Price low | $65.71 | 10 Mar 2023 |
| Average price | $70.50 | |
| Sentiment high | 84Extreme Greed | 4 Jan 2023 |
| Sentiment low | 18Extreme Fear | 10 Mar 2023 |
| Average sentiment | 45Neutral | |
| Most volatile day (price) | -2.9% | 9 Feb 2023 |
| Most volatile day (sentiment) | -34 points (84 to 50) | 6 Jan 2023 |
61 scored trading days of 65. Price is the BMY price; performance is the first to the last scored day.
Q1 2023 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q1 2023, in its own band colour.
- Price45
- Volatility49
- Volume55
- Momentum47
- Technical47
- Socialn/a
- Dominance28
- Trendsn/a
- Whalesn/a
- Orders39
Q1 2023 in brief
Bristol Myers Squibb averaged 45 of 100 (Neutral) across 61 scored trading days in Q1 2023, opening at 84 on 4 Jan 2023 and closing at 59 on 31 Mar 2023. Sentiment ran from 18 (Extreme Fear) on 10 Mar 2023 to 84 (Extreme Greed) on 4 Jan 2023. The BMY price moved -4.6% from $72.62 to $69.31, with its biggest single-day move of -2.9% on 9 Feb 2023.
How these reports are built
Each quarter is computed from CFGI's stored daily readings of the Fear and Greed Index: the last 1d reading of every UTC day in the window, its 10 components and the stored daily BMY price. Averages are over scored trading days only. A running quarter updates with every data cycle; a closed quarter is final. Cite as: CFGI, Bristol Myers Squibb Quarterly Sentiment Reports, cfgi.io, 8 Sep 2026, https://cfgi.io/bristol-myers-squibb-stock-quarterly-report/.
Frequently asked questions
Where do these Bristol Myers Squibb quarterly reports come from?
What is the most volatile day?
How does a quarter get a Partial record tag?
Where are the monthly reports?
CFGI is a sentiment gauge, not financial advice. It does not predict price or tell users when to trade. These reports describe what the crowd did; they are a mirror of the crowd, not a forecast.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.